[go: up one dir, main page]

UY29893A1 - Derivados de pirazina - Google Patents

Derivados de pirazina

Info

Publication number
UY29893A1
UY29893A1 UY29893A UY29893A UY29893A1 UY 29893 A1 UY29893 A1 UY 29893A1 UY 29893 A UY29893 A UY 29893A UY 29893 A UY29893 A UY 29893A UY 29893 A1 UY29893 A1 UY 29893A1
Authority
UY
Uruguay
Prior art keywords
compounds
pirazine
derivatives
preparation
pirazine derivatives
Prior art date
Application number
UY29893A
Other languages
English (en)
Inventor
Stephen Mark Denton
Malanie Susanne Glossop
Mark Ian Kemp
Cedric Poinsard
Karl Richard Gibson
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of UY29893A1 publication Critical patent/UY29893A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención se refiere a compuestos de fórmula y a sales y solvatos farmacéuticamente aceptables de los mismos, a procedimientos para su preparación, a intermedios útiles en su preparación y a composiciones que contienen dichos compuestos, y a los usos de dichos compuestos para el tratamiento de dolor.
UY29893A 2005-11-04 2006-11-01 Derivados de pirazina UY29893A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73366205P 2005-11-04 2005-11-04

Publications (1)

Publication Number Publication Date
UY29893A1 true UY29893A1 (es) 2007-06-29

Family

ID=37890558

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29893A UY29893A1 (es) 2005-11-04 2006-11-01 Derivados de pirazina

Country Status (27)

Country Link
US (1) US7572797B2 (es)
EP (1) EP1945630B1 (es)
JP (1) JP2009514937A (es)
KR (1) KR20080066073A (es)
CN (1) CN101356169A (es)
AP (1) AP2008004468A0 (es)
AR (1) AR057855A1 (es)
AT (1) ATE525372T1 (es)
AU (1) AU2006310215A1 (es)
BR (1) BRPI0618129A2 (es)
CA (1) CA2624621C (es)
CR (1) CR9954A (es)
DO (1) DOP2006000243A (es)
EA (1) EA200801011A1 (es)
EC (1) ECSP088412A (es)
ES (1) ES2371932T3 (es)
GT (1) GT200600475A (es)
IL (1) IL191059A0 (es)
MA (1) MA29926B1 (es)
NL (1) NL2000284C2 (es)
NO (1) NO20082496L (es)
PE (1) PE20070715A1 (es)
TN (1) TNSN08196A1 (es)
TW (1) TW200804353A (es)
UY (1) UY29893A1 (es)
WO (1) WO2007052123A2 (es)
ZA (1) ZA200803671B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1094757C (zh) 1996-07-24 2002-11-27 沃尼尔·朗伯公司 用于治疗疼痛的异丁基γ－氨基丁酸及其衍生物
EP1741708A1 (en) * 2005-06-28 2007-01-10 Sanofi-Aventis Deutschland GmbH Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
BRPI0810202A2 (pt) 2007-05-03 2014-10-21 Pfizer Ltd Derivados de piridina
US20100227872A1 (en) * 2007-05-03 2010-09-09 Mark Ian Kemp Pyrazine derivatives
WO2009026434A1 (en) * 2007-08-21 2009-02-26 Alkermes, Inc. Pulmonary pharmaceutical formulations
AR069637A1 (es) 2007-12-10 2010-02-10 Novartis Ag Derivados de pirazinas
JPWO2009101917A1 (ja) 2008-02-13 2011-06-09 エーザイ・アール・アンド・ディー・マネジメント株式会社 ビシクロアミン誘導体
MX2010012814A (es) 2008-05-23 2010-12-20 Amira Pharmaceuticals Inc Inhibidor de proteina activadora de 5-lipoxigenasa.
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US10703722B2 (en) 2010-04-27 2020-07-07 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2013059677A1 (en) * 2011-10-19 2013-04-25 Calcimedica, Inc. Compounds that modulate intracellular calcium
RU2646754C2 (ru) * 2012-04-25 2018-03-07 Раквалиа Фарма Инк. Производные пирролопиридинона в качестве ttx-s блокаторов
TWI644899B (zh) * 2013-02-04 2018-12-21 健生藥品公司 Ｆｌａｐ調節劑
JP6424173B2 (ja) 2013-02-04 2018-11-14 ヤンセン ファーマシューティカ エヌ．ベー． Ｆｌａｐ調節因子
CA2960274A1 (en) 2014-09-10 2016-03-17 Epizyme, Inc. Isoxazole carboxamide compounds
TWI835179B (zh) 2015-02-27 2024-03-11 美商鈣系醫藥公司 胰腺炎治療
DK3331525T3 (da) 2015-08-07 2020-12-14 Calcimedica Inc Anvendelse af CRAC-kanal-inhibitorer til behandling af slagtilfælde og traumatisk hjerneskade
GB201801128D0 (en) 2018-01-24 2018-03-07 Univ Oxford Innovation Ltd Compounds
EP4243813A4 (en) 2020-11-13 2024-07-17 Calcimedica, Inc. IMPROVED SYNTHESIS OF CRAC CHANNEL INHIBITORS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA26473A1 (fr) * 1997-03-01 2004-12-20 Glaxo Group Ltd Composes pharmacologiquement actifs.
AU2002343557A1 (en) * 2001-11-21 2003-06-10 Pharmacia And Upjohn Company Substituted aryl 1,4-pyrazine derivatives
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
CA2543644A1 (en) * 2003-10-27 2005-05-06 Astellas Pharma Inc. Pyrazine derivatives and pharmaceutical use thereof
CN101084208A (zh) * 2004-10-22 2007-12-05 詹森药业有限公司 作为c－fms激酶抑制剂的芳族酰胺

Also Published As

Publication number Publication date
AP2008004468A0 (en) 2008-06-30
EA200801011A1 (ru) 2009-02-27
ES2371932T3 (es) 2012-01-11
GT200600475A (es) 2007-07-06
KR20080066073A (ko) 2008-07-15
WO2007052123A3 (en) 2007-07-12
BRPI0618129A2 (pt) 2011-08-16
AR057855A1 (es) 2007-12-19
US7572797B2 (en) 2009-08-11
AU2006310215A1 (en) 2007-05-10
DOP2006000243A (es) 2007-05-31
CR9954A (es) 2008-05-28
ATE525372T1 (de) 2011-10-15
NL2000284C2 (nl) 2007-09-28
ECSP088412A (es) 2008-05-30
CN101356169A (zh) 2009-01-28
CA2624621A1 (en) 2007-05-10
PE20070715A1 (es) 2007-08-11
JP2009514937A (ja) 2009-04-09
MA29926B1 (fr) 2008-11-03
ZA200803671B (en) 2009-03-25
NL2000284A1 (nl) 2007-05-07
TW200804353A (en) 2008-01-16
CA2624621C (en) 2010-11-30
IL191059A0 (en) 2008-12-29
WO2007052123A2 (en) 2007-05-10
EP1945630B1 (en) 2011-09-21
NO20082496L (no) 2008-07-24
EP1945630A2 (en) 2008-07-23
US20070105872A1 (en) 2007-05-10
TNSN08196A1 (fr) 2009-10-30

Similar Documents

Publication Publication Date Title
CR9954A (es) Derivados de pirazina
ECSP077185A (es) Derivados de piridina
DOP2009000254A (es) Derivados de piridina
ECSP11011198A (es) Derivados de sulfonamida
AR055076A1 (es) Derivados de1,1-dioxido de 1,4-benzotiazepina,procedimiento para prepararlos,composiciones farmaceuticas que los contienen y usos en terapeutica.
ECSP099706A (es) Nuevos derivados de n-(8-heteroariltetrahidronaftalen-2yl) y n-(5-heteroarilcroman-3-il) carboxamida para el tratamiento del dolor
UY30681A1 (es) Compuestos de piridinamida que contienen carboxi, sales farmacéuticamente aceptables, procedimientos para la preparacion de los mismos, composiciones que los contienen y sus usos.
UY31481A1 (es) Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones
ECSP10010693A (es) Compuestos pirazólicos 436
UY31906A (es) Derivados de n-cicloalquil-3-fenilnicotinamida que inhiben pgds, sus composiciones, su uso para el tratamiento por ejemplo de afecciones alérgicas y respiratorias.
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
UY31885A (es) Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones.
PA8604201A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
HN2008001666A (es) Derivados acidos de cicloalquilamino
ECSP088700A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
CO6321280A2 (es) Nueva clase espiro piperidinas para el tratamiento de enfermedades neurodegenerativas
PA8627001A1 (es) Compuestos para el tratamiento de enfermedades
UY29818A1 (es) Nuevos compuestos de azetidina, composiciones farmaceuticas que los contienen, procesos de preparacion y sus usos terapeuticos
PA8589801A1 (es) Aminoalcoxiindoles
UY30356A1 (es) Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos.
GT200600161A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos
UY28357A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparación de los mismos y sus usos
ECSP099679A (es) Nuevos compuestos y sus usos 707
UY29817A1 (es) Nuevos compuestos de azetidina, composiciones farmacéuticas que los contienen, procesos de preparación y uso terapéutico de los mismos.
UY29308A1 (es) Derivado de quinolina, su uso, preparación y medicamento que lo contiene

Legal Events

Date Code Title Description
104 Application deemed to be withdrawn (no substantive examination fee paid)

Effective date: 20131105